![Namandje Bumpus](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Net worth: 458 199 $ as of 30/05/2026
Namandje N.
Bumpus is an Independent Director at Recursion Pharmaceuticals, Inc. since 2025.
Dr. Bumpus is Senior VP, Chief Innovation & Scientific Officer at Charles River Laboratories International, Inc. since 2026.
Dr. Bumpus is a Venture Partner at F-Prime Inc. since 2025.
Formerly, Dr. Bumpus was a Director at AI Proteins, Inc. Dr. Bumpus was a Professor at The Johns Hopkins University School of Medicine from 2020 to 2022.
Dr. Bumpus completed undergraduate studies at Occidental College in 2003 and earned a doctorate from the University of Michigan in 2007.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 17/06/2026 | 127,632 ( 0.02% ) | 458 199 $ | 30/05/2026 |
| Companies | Position | Start |
|---|---|---|
| RECURSION PHARMACEUTICALS, INC. | Director/Board Member | 14/03/2025 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Chief Tech/Sci/R&D Officer | 11/01/2026 |
Impresa Management LLC
 Impresa Management LLC Investment ManagersFinance F-Prime invests in companies located in Asia, Europe, North America and South America. The firm targets companies operating in the fields of life sciences, technology, healthtech & services and crypto sectors. It provides financing for seed, early and later stage transactions. | Private Equity Investor | 30/04/2025 |
| Companies | Position | End |
|---|---|---|
The Johns Hopkins University School of Medicine
 The Johns Hopkins University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 31/12/2021 |
AI Proteins, Inc.
 AI Proteins, Inc. Packaged SoftwareTechnology Services Develops AI powered protein therapeutics discovery platform | Director/Board Member | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 7 |
|---|---|
Charles River Laboratories International, Inc.
 Charles River Laboratories International, Inc. Miscellaneous Commercial ServicesCommercial Services Provides laboratory testing and research services on a contract basis | Commercial Services |
Recursion Pharmaceuticals, Inc.
 Recursion Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that combines biology, chemistry, automation, data science and engineering to industrialize drug discovery | Health Technology |
Occidental College
 Occidental College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Johns Hopkins University School of Medicine
The Johns Hopkins University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Impresa Management LLC
Impresa Management LLC Investment ManagersFinance F-Prime invests in companies located in Asia, Europe, North America and South America. The firm targets companies operating in the fields of life sciences, technology, healthtech & services and crypto sectors. It provides financing for seed, early and later stage transactions. | Finance |
AI Proteins, Inc.
AI Proteins, Inc. Packaged SoftwareTechnology Services Develops AI powered protein therapeutics discovery platform | Technology Services |
Select your edition
All financial news and data tailored to specific country editions
